← All Sponsors
SPONSOR

Peking Union Medical College Hospital

Total Trials
27
Recruiting
27
Phases
Phase 3, EARLY_Phase 1, Phase 2, Phase 1, Phase 2
NCT06006832
Recruiting

A Prospective Cohort Study of Myasthenia Gravis in China

Myasthenia Gravis
NCT06375473
Recruiting

Treatment of Irinotecan Hydrochloride Liposome Injection II in China: a Real World Study of Pancreatic Cancer Patients

Pancreatic Cancer
NCT06387823
Recruiting

Efficacy and Safety of Sivelestat Sodium and Dexamethasone in the Treatment of ARDS

Acute Respiratory Distress Syndrome
NCT06674460 Phase 3
Recruiting

Treatment of Acute Ischemic Stroke With Edaravone Dexborneol Sublingual Tablets in Small Vessel Disease

Cerebral Small Vessel Disease
NCT06898437 EARLY_Phase 1
Recruiting

Study of 177Lu-LNC1004 Injection in FAP-positive Radioiodine-refractory Differentiated Thyroid Cancer

Radioiodine Refractory Differentiated Thyroid Cancer
NCT06632873 EARLY_Phase 1
Recruiting

177Lu-TATE-RGD in Patients With SSTR2 and Integrin αVβ3 Positive Tumors

SSTR2 and Integrin αVβ3 Positive Tumors
NCT05925023
Recruiting

Sirolimus in the Treatment of Refractory/Relapsed wAIHA

Warm Autoimmune Hemolytic Anemia
NCT07083973
Recruiting

Prone Position Assessed by 3D EIT

ARDS (Acute Respiratory Distress Syndrome)
NCT03193892
Recruiting

A National Registry on Chinese Patients With Lymphangioleiomyomatosis

Pulmonary Function
NCT06421805
Recruiting

Establishing Prospective Mediastinal Tumor Database of PUMCH

Thymic Epithelial Tumor
NCT05845723 Phase 2
Recruiting

Tocilizumab and Tofacitinib in the Treatment of Vascular Behçet's Syndrome

Aneurysm
NCT07453342
Recruiting

Immune-Related Adverse Events After Cancer Immunotherapy and Safety of Treatment Rechallenge

Immune-Related Adverse Events
NCT06454968 Phase 2
Recruiting

Orelabrutinib Combined With Obinutuzumab and Lenalidomide (OGL Regimen) as First-line Treatment for Marginal Zone Lymphoma.

Marginal Zone Lymphoma
NCT06836869
Recruiting

Modified Tumor-free Techniques Operation to Cervical Cancer

Cervical Cancer Stage IB2
NCT06774209
Recruiting

Multimodal PET Imaging in the Diagnosis and Treatment of Pelvic Tumors

Endometrial Cancer
NCT04312854
Recruiting

A Prospective Cohort Study of IRPF in China

Idiopathic Retroperitoneal Fibrosis
NCT06941766 Phase 1, Phase 2
Recruiting

Iparomlimab and Tuvonralimab (QL1706) for Intermediate Trophoblastic Tumors

Intermediate Trophoblastic Tumor
NCT05289245
Recruiting

A National Registry on Chinese Patients With Cystic Fibrosis

Pulmonary Function
NCT07001943
Recruiting

Correlation Study Between SMA Blood Flow Reactivity and Acute Gastrointestinal Injury in Critically Ill Patients

Intestinal Ischemia
NCT06433817
Recruiting

Spectral CT in Radiotherapy for Cervical Cancer

Cervical Cancer
NCT06867120
Recruiting

Bowel Sound in Predicting the Severity of Acute Pancreatitis: Protocol of a Prospective, Multi-center Study

Acute Pancreatitis (AP)
NCT06824883 Phase 2
Recruiting

Sintilimab, Pegaspargase Plus GemOx for Untreated Extranodal NK/T-Cell Lymphoma

Extranodal NK/T-cell Lymphoma
NCT05751018 Phase 2
Recruiting

Phase II Clinical Study of Pyrotinib in First-line Treatment of Primary HER2-amplified/Mutated Advanced Non-small Cell Lung Cancer

Non-small Cell Lung Cancer
NCT06412952 EARLY_Phase 1
Recruiting

68Ga-NOTA-RM26 PET/CT in Glioma Patients

Glioma
NCT07190079
Recruiting

Saline Contrast Electrical Impedance Tomography Method for Diagnosis of Acute Pulmonary Embolism

Acute Pulmonary Embolism
NCT05899725
Recruiting

The Efficacy and Safety of Corticosteroids in Combination With Ruxolitinib in the Management of Checkpoint Inhibitor Pneumonia

Severe Checkpoint Inhibitor Pneumonitis
NCT05996016
Recruiting

Gut and Vaginal Microbiota Profile Study for HIV Women

HPV